Gastrointestinal effects dominate the tolerability picture Across the Phase 2 obesity, MASH, and diabetes trials, the most consistent finding is a high rate of gastrointestinal adverse events nausea, vomiting, and diarrhea substantially more frequent than placebo
For example, acceptable sterility levels include 10 colony forming units (cfu) per gram of formulation or composition, 50 cfu per gram of formulation or composition, 100 cfu per gram of formulation or composition, 500 cfu per gram of formulation or composition or 1000 cfu per gram of formulation or composition
10.1016/S0006-8993(97)01200-6 Brain Res
Am J Anat 71:451480
NF-B is the central regulator of the cutaneous inflammatory cascadeby blocking it, KPV reduces the production of IL-1, TNF-, IL-6, PGE2, and NO